These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7030291)

  • 1. Use of captopril in the diagnosis of renal hypertension.
    McGrath BP; Matthews PG; Johnston CI
    Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
    McGrath BP; Matthews PG; Johnston CI
    Clin Exp Pharmacol Physiol; 1980; 7(5):487-91. PubMed ID: 7004680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB; Atlas SA; Laragh JH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
    Johnston CI; Millar JA; McGrath BP; Matthews PG
    Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
    Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
    Matthews PG; McGrath BP; Johnston CI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril in renovascular hypertension: long-term use in predicting surgical outcome.
    Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):689-93. PubMed ID: 6802290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
    Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
    Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
    Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI
    Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension].
    Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T
    Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound.
    Fagard R; Amery A; Lijnen P; Roussel-Deruyck R
    Acta Clin Belg; 1982; 37(1):13-22. PubMed ID: 7046321
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of captopril on the renin-angiotensin system in hypertensive children.
    Friedman AL; Chesney RW
    J Pediatr; 1983 Nov; 103(5):806-10. PubMed ID: 6355422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.